




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Nuclear Imaging</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=11352aee-29c3-41c9-88b5-d386d20124c1</link>
        <description>Clinical Topic Feed: Nuclear Imaging</description>
        <language>en</language>

        

                <item>
                    <title>Follow-Up of FAVOR III Suggests QFR-Guided PCI Improves 5-Year Outcomes</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/06/08/17/44/Follow-Up-of-FAVOR-III</link>                    <description>When compared with angiography guidance, quantitative flow ratio (QFR)-guided PCI improved five-year clinical outcomes with benefits primarily achieved in the first two years, according to a follow-up study of the multicenter, sham-controlled FAVOR III trial published June 10 in JACC.</description>
                    <pubdate>1781194140000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: ED Patients With &#226;€˜Low Risk&#226;€™ Chest Pain Often Deferred Future Testing </title>
<link>/Latest-in-Cardiology/Articles/2026/06/03/13/24/eagles-eye-view-03jun2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at recent research found in ACC&#226;€™s new expert decision pathway for postpartum cardiovascular care. He then offers insights from the ACC Chest Pain - MI Registry examining &#226;€˜low risk&#226;€™ chest pain and its evaluation in the emergency departments.</description>
                    <pubdate>1780493220000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Cover Story | Tricuspid Valve Intervention: Clinical Decision-Making For Patient Selection</title>
<link>/Latest-in-Cardiology/Articles/2026/06/01/01/Cover-Story-Tricuspid-Valve-Intervention</link>                    <description>For decades, cardiologists have referred to the tricuspid valve as &quot;the forgotten valve.&quot; One reason for this neglect is that tricuspid regurgitation (TR) often goes unnoticed, explains Robert O. Bonow, MD, MACC, Distinguished Professor at Northwestern University Feinberg School of Medicine in Chicago, IL.</description>
                    <pubdate>1780316340000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Rise in Deferral of Further Testing in Patients With Low-Risk Chest Pain | NCDR Study</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/26/10/02/Rise-in-Deferral</link>                    <description>In the evaluation of patients with low-risk chest pain, there has been a rise in the deferral of further testing, with lower rates of functional testing and invasive coronary angiography (ICA), and significant variation at the site level in the proportion of patients who underwent further noninvasive testing...</description>
                    <pubdate>1779801480000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Explore NCDR Science Presented at HRS 2026</title>
<link>/Latest-in-Cardiology/Articles/2026/04/24/16/43/Explore-NCDR-Science-Presented-at-HRS-2026</link>                    <description>Several abstracts being presented at HRS 2026 in Chicago are using NCDR data. The research explores trends and outcomes related to irrigated radiofrequency catheters for accessory pathway ablation in pediatric patients, ICD procedures in patients with ventricular assist devices, and intracardiac echocardiography...</description>
                    <pubdate>1777050060000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>IVUS-CHIP and OPTIMAL: IVUS-Guided vs. Angiography-Guided PCI</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/mon-1045am-combo-acc-2026</link>                    <description>When compared with angiography-guided PCI, IVUS-guided PCI was found to be not superior in patients with complex coronary arteries according to results from the IVUS-CHIP trial or in patients with unprotected left main coronary artery disease (LM-CAD) according to results from the OPTIMAL trial. Both trials were presented in a Late-Breaking Clinical Trial session at ACC.26 in New Orleans.</description>
                    <pubdate>1774885860000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>DKCRUSH VIII: IVUS-Guided PCI Superior to Angiography-Guided PCI in Complex Coronary Lesions</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/mon-1045am-dkcrush-acc-2026</link>                    <description>When using the two-stent double-kissing (DK) crush technique for PCI to treat complex coronary artery bifurcation lesions, IVUS-guided PCI was associated with a greater reduction in target vessel failure compared to angiography-guided PCI, according to the DKCRUSH VIII trial presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in JACC.</description>
                    <pubdate>1774885560000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ALL-RISE: AI-Supported Coronary Flow Assessment Performs Similarly to Gold-Standard Wire-Based Testing</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-830am-allrise-acc-2026</link>                    <description>FFRangio, a minimally invasive, artificial intelligence (AI)-assisted, novel method of measuring fractional flow reserve (FFR), performed similarly to traditional wire-based testing in patients with coronary artery disease (CAD) undergoing assessment for PCI, according to results from the ALL-RISE trial presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in NEJM.</description>
                    <pubdate>1774791240000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>CHIP-BCIS3: LV Unloading Not Beneficial During PCI in Patients With Severe LV Dysfunction</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-830am-chip-bcis3-acc-2026</link>                    <description>Among patients with severe left ventricular (LV) dysfunction and severe coronary heart disease undergoing complex PCI, elective LV unloading with a microaxial flow pump did not reduce the risk of major adverse clinical outcomes and carried a greater risk of all-cause and cardiovascular mortality...</description>
                    <pubdate>1774791180000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>FAST III: Novel Minimally Invasive vFFR Noninferior to FFR For Revascularization</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-830am-fastIII-acc-2026</link>                    <description>Vessel fractional flow reserve (vFFR)-guided revascularization was noninferior to pressure-wire-based fractional flow reserve (FFR)-guided revascularization in patients with intermediate coronary lesions, according to results from the FAST III trial presented during a Late-Breaking Clinical Trials session...</description>
                    <pubdate>1774791180000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>